Annual report
4188.TEDINET S100W27P
Period2024-04-01 → 2025-03-31
Filed2025-06-23
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Amended by S100WZVZ (2025-11-12).
Key figures · 160
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.41T | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥4.39T | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥4.63T | 2022-04-01 → 2023-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.98T | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.26T | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥196.7bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥261.8bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥150.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥240.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥168.0bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥290.4bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥32.9bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥45.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥119.6bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥96.5bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥177.2bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥7.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥105.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥178.4bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥135.5bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥209.4bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥22.7bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥5.89T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥6.10T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥5.77T | at 2023-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥5.57T | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥5.29T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.61T | at 2025-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.83T | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.28T | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.28T | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.99T | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.74T | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.76T | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.56T | at 2023-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.46T | at 2022-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.24T | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥326.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥294.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥297.2bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥245.8bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥349.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥552.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥465.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥355.2bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥346.9bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥467.1bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥275.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥246.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥247.6bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥128.8bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥217.0bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥246.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥241.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥60.8bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥336.3bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥142.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥31.64 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥84.07 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥67.85 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥124.68 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-5.32 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥31.63 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥80.77 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥64.99 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥115.03 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-5.32 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,223.01 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,239.61 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,100.27 | at 2023-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,026.03 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥870.4 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 29.5% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 28.9% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 27.1% | at 2023-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 23.4% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 2.6% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.2% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.4% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 13.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -0.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 63,258 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 66,358 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 68,639 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 69,784 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 69,607 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥75.8bn | 2024-04-01 → 2025-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥212.0bn | 2023-04-01 → 2024-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥125.3bn | 2022-04-01 → 2023-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥69.5bn | 2021-04-01 → 2022-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥24.7bn | 2020-04-01 → 2021-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥55.6bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥190.4bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥51.6bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥186.6bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥103.1bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥52.6bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.4bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥51.6bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥189.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥137.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥188.8bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥104.5bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥56.2bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥11.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.97T | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥1.99T | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥2.01T | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.80T | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.99T | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.27T | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.38T | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥706.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥614.5bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥471.4bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥409.7bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥392.3bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥22.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥26.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥96.73 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥132.74 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.51 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.56 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.37 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥96.71 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥127.46 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥70.41 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥36.62 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥7.87 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥32 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥32 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥496.53 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥431.67 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥329.8 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥286.54 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥273.62 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.8% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.3% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.7% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 20.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 34.9% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 23.9% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,506,288,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,506,288,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,506,288,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,506,288,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,506,288,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 414 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 501 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 430 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 223 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 201 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 88
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 6257 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥335.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥190.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥145.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥253.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥13.4bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥211.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥211.8bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | −¥358.6bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥11.4bn |
| Basic Materials And Polymersreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥46.8bn |
| Basic Materials And Polymersreportable segment | employees | at 2025-03-31 | 6572 pure |
| Basic Materials And Polymersreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.01T |
| Basic Materials And Polymersreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥972.4bn |
| Basic Materials And Polymersreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥34.8bn |
| Basic Materials And Polymersreportable segment | segment assets | at 2025-03-31 | ¥704.4bn |
| Basic Materials And Polymersreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥15.6bn |
| Industrial Gasesreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥142.4bn |
| Industrial Gasesreportable segment | employees | at 2025-03-31 | 19762 pure |
| Industrial Gasesreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.31T |
| Industrial Gasesreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.30T |
| Industrial Gasesreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥6.9bn |
| Industrial Gasesreportable segment | segment assets | at 2025-03-31 | ¥2.46T |
| Industrial Gasesreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥186.1bn |
| MMA And Derivativesreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥23.4bn |
| MMA And Derivativesreportable segment | employees | at 2025-03-31 | 3995 pure |
| MMA And Derivativesreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥416.4bn |
| MMA And Derivativesreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥402.1bn |
| MMA And Derivativesreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥14.3bn |
| MMA And Derivativesreportable segment | segment assets | at 2025-03-31 | ¥529.2bn |
| MMA And Derivativesreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥35.3bn |
| Pharmareportable segment | capex | 2024-04-01 → 2025-03-31 | ¥7.9bn |
| Pharmareportable segment | employees | at 2025-03-31 | 4490 pure |
| Pharmareportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥460.4bn |
| Pharmareportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥460.3bn |
| Pharmareportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥92m |
| Pharmareportable segment | segment assets | at 2025-03-31 | ¥963.0bn |
| Pharmareportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥65.4bn |
| Specialty Materialsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥114.6bn |
| Specialty Materialsreportable segment | employees | at 2025-03-31 | 21260 pure |
| Specialty Materialsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.09T |
| Specialty Materialsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.08T |
| Specialty Materialsreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥10.3bn |
| Specialty Materialsreportable segment | segment assets | at 2025-03-31 | ¥1.34T |
| Specialty Materialsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥25.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥4.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥354.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥204.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥149.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥274.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥13.6bn |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥3.1bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥220.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥220.7bn |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | −¥398.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥12.4bn |
| Basic Materials And Polymersreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥39.2bn |
| Basic Materials And Polymersreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.15T |
| Basic Materials And Polymersreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.11T |
| Basic Materials And Polymersreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥39.0bn |
| Basic Materials And Polymersreportable segment | segment assets | at 2024-03-31 | ¥858.9bn |
| Basic Materials And Polymersreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥25.4bn |
| Industrial Gasesreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥126.3bn |
| Industrial Gasesreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.26T |
| Industrial Gasesreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.25T |
| Industrial Gasesreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥8.2bn |
| Industrial Gasesreportable segment | segment assets | at 2024-03-31 | ¥2.45T |
| Industrial Gasesreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥163.0bn |
| MMA And Derivativesreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥25.0bn |
| MMA And Derivativesreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥361.8bn |
| MMA And Derivativesreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥347.9bn |
| MMA And Derivativesreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥13.9bn |
| MMA And Derivativesreportable segment | segment assets | at 2024-03-31 | ¥590.2bn |
| MMA And Derivativesreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥5.5bn |
| Pharmareportable segment | capex | 2023-04-01 → 2024-03-31 | ¥5.1bn |
| Pharmareportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥437.4bn |
| Pharmareportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥437.2bn |
| Pharmareportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥138m |
| Pharmareportable segment | segment assets | at 2024-03-31 | ¥933.6bn |
| Pharmareportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥56.3bn |
| Specialty Materialsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥80.9bn |
| Specialty Materialsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.05T |
| Specialty Materialsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.04T |
| Specialty Materialsreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥9.8bn |
| Specialty Materialsreportable segment | segment assets | at 2024-03-31 | ¥1.39T |
| Specialty Materialsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥7.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,436
| Item | Context | Value | Unit |
|---|---|---|---|
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000SakamotoShuichiMember | Original text (Japanese)社外取締役 | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000SakamotoShuichiMember | Original text (Japanese)坂本 修一 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000SakamotoShuichiMember | 1957-10-13 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E00808-000SakamotoShuichiMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000SakamotoShuichiMember | Original text (Japanese)(注1)(注2)(注3) | |
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000GeoffreyCoatesMember | Original text (Japanese)社外取締役 | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000GeoffreyCoatesMember | Original text (Japanese)ジェフリー・コーツ | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000GeoffreyCoatesMember | 1966-10-12 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E00808-000GeoffreyCoatesMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000GeoffreyCoatesMember | Original text (Japanese)(注1)(注2) | |
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000KuraishiSeijiMember | Original text (Japanese)社外取締役 | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000KuraishiSeijiMember | Original text (Japanese)倉石 誠司 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000KuraishiSeijiMember | 1958-07-10 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E00808-000KuraishiSeijiMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00808-000KuraishiSeijiMember | Original text (Japanese)(注1)(注2)(注3) | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000ChikumotoManabuMember | Original text (Japanese)代表執行役執行役社長 | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000ChikumotoManabuMember | Original text (Japanese)筑本 学 | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000ChikumotoManabuMember | 1964-06-26 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E00808-000ChikumotoManabuMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000ChikumotoManabuMember | Original text (Japanese)(注) | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000YanoIsaoMember | Original text (Japanese)代表執行役チーフコンプライアンスオフィサー(法務、コンプライアンス、総務、広報、コーポレート・セクレタリー所管) | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000YanoIsaoMember | Original text (Japanese)矢野 功 | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000YanoIsaoMember | 1965-08-17 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E00808-000YanoIsaoMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000YanoIsaoMember | Original text (Japanese)(注) | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000ArakiKenMember | Original text (Japanese)執行役チーフトランスフォーメーションオフィサー(サステナビリティ、ストラテジー、ERM、デジタル、事業開発所管) | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000ArakiKenMember | Original text (Japanese)荒木 謙 | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000ArakiKenMember | 1966-07-29 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E00808-000ArakiKenMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E00808-000ArakiKenMember | Original text (Japanese)(注) | |
| Footnotes executive officers (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | - | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | - | |
| Name of group company holding largest amount of investment shares in group | CurrentYearInstant | Original text (Japanese)三菱ケミカル㈱ | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment largest holding company | CurrentYearDuration | Original text (Japanese)関係会社株式の売却による投資株式への保有目的変更により増加しております。 | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment largest holding company | CurrentYearDuration | - | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)㈱三菱総合研究所 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row2Member | Original text (Japanese)三菱瓦斯化学㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row2Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row2Member | Original text (Japanese)有 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |